Muscular dystrophy linked to muscle weakness highlights need for early diagnosis and new treatments

Muscular Dystrophy (MD) is a genetic disorder that leads to progressive muscle weakness and can affect vital organs. Early diagnosis and multidisciplinary care are essential for managing the condition. New treatments, including gene therapy and stem cell research, show promise. Different types of MD have varying impacts. Duchenne MD typically starts in childhood, while Becker MD progresses more slowly. Other forms, like Myotonic and Facioscapulohumeral MD, affect different muscle groups and can lead to additional complications. Current treatments focus on slowing muscle degeneration and improving quality of life. Physical therapy, medications, and nutritional support are key components. Research advancements in gene therapy and early genetic testing are crucial for better outcomes in MD management.